Skip to main content
. 2021 Sep 7;9(9):998. doi: 10.3390/vaccines9090998

Figure 2.

Figure 2

Quality assessment of the included trials, using the Risk of Bias-2 (RoB-2) (a) or the Risk of Bias in Non-Randomised Studies of Interventions (ROBINS-I) (b) of the Cochrane Collaboration tool, based on study design.